Augmented Reality for Loneliness
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment 2-D AV, HMD AR for loneliness?
Research suggests that Virtual Reality (VR), which is similar to Augmented Reality (AR), can help reduce loneliness by creating spaces for group activities, rather than just passive content consumption. This approach has been explored in older adults, indicating potential benefits for loneliness reduction.12345
Is augmented reality safe for reducing loneliness?
How does the Augmented Reality treatment for loneliness differ from other treatments?
The Augmented Reality treatment for loneliness is unique because it uses immersive technology to create interactive social experiences, which can help reduce feelings of loneliness by facilitating group activities and enhancing social connections, unlike traditional methods that may not offer such engaging and interactive environments.36101112
What is the purpose of this trial?
The goal of this clinical trial is to test the use of head-mounted display (HMD) augmented reality (AR) in older adults residing in long term care communities. The main questions it aims to answer are: what is the feasibility, acceptability, and satisfaction of HMD AR vs two-dimensional audio-video communication? Older adults and their designated family member will complete HMD AR activities in 8 session visits over 4 weeks. Researchers will compare HMD AR to 2-D audio-visual (AV) comparison group on feasibility, acceptability, and satisfaction with the interactive communication technology.
Research Team
Nilanjan Sarkar
Principal Investigator
Vanderbilt University
Eligibility Criteria
This trial is for older adults aged 60 or above who have been living in long-term care facilities for more than three months. Participants must be able to give consent and understand English. Those with physical impairments that prevent participation or those who are terminally ill cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in collaborative activities using HMD AR or 2-D Audio-Visual technology in 8 sessions over 4 weeks
Follow-up
Participants are monitored for feasibility, acceptability, and satisfaction of the intervention
Treatment Details
Interventions
- 2-D AV
- HMD AR
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator